Viewing Study NCT04730258

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2025-12-25 @ 10:16 PM
Study NCT ID: NCT04730258
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-18
First Post: 2021-01-25
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML
Sponsor: Treadwell Therapeutics, Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Myelodysplastic Syndromes View
None Chronic Myelomonocytic Leukemia View
None AML View
None MDS View
None CMML View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Polo-like kinase 4 View
None PLK4 View
None serine/threonine kinase Polo-like kinase 4 View
None CFI-400945 View
None 945 View
None Polo-Like Kinase 4 inhibitors/antagonists View
None hematologic malignancies View
None PLK-4 View
None UHN View
None University Health Network View
None Treadwell View
None Treadwell Therapeutics View
None Treadwell Tx View